Disc Medicine Files 8-K on Officer/Director Changes
Ticker: IRON · Form: 8-K · Filed: Oct 6, 2025 · CIK: 1816736
| Field | Detail |
|---|---|
| Company | Disc Medicine, Inc. (IRON) |
| Form Type | 8-K |
| Filed Date | Oct 6, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes
TL;DR
Disc Medicine 8-K: Leadership changes reported as of Oct 3, 2025.
AI Summary
Disc Medicine, Inc. filed an 8-K on October 6, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. The filing covers events as of October 3, 2025, and includes information about the company's principal executive offices in Watertown, Massachusetts.
Why It Matters
This filing indicates potential shifts in the company's leadership or governance structure, which could impact strategic direction and investor confidence.
Risk Assessment
Risk Level: low — The filing reports routine corporate governance events and does not disclose significant financial or operational risks.
Key Numbers
- 001-39438 — SEC File Number (Identifies the company's filing with the SEC.)
- 851613057 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Disc Medicine, Inc. (company) — Registrant
- Gemini Therapeutics, Inc. (company) — Former company name
- FS Development Corp. (company) — Former company name
- Watertown, Massachusetts (location) — Principal executive offices location
FAQ
What specific officer or director positions were affected by the events reported on October 3, 2025?
The filing indicates changes related to 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers,' but does not specify the individuals or exact roles in the provided text.
Were there any new compensatory arrangements disclosed for officers or directors?
The filing lists 'Compensatory Arrangements of Certain Officers' as an item covered, but the details of these arrangements are not provided in the excerpt.
When was the company formerly known as Gemini Therapeutics, Inc.?
The date of the name change from Gemini Therapeutics, Inc. was February 9, 2021.
What is the business address of Disc Medicine, Inc.?
The principal executive offices are located at 321 Arsenal Street, Suite 101, Watertown, Massachusetts 02472.
What is the SIC code for Disc Medicine, Inc.?
The Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 478 words · 2 min read · ~2 pages · Grade level 10.2 · Accepted 2025-10-06 16:20:46
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share IRON The Nasdaq Global Ma
Filing Documents
- iron-20251003.htm (8-K) — 40KB
- 0001193125-25-231911.txt ( ) — 142KB
- iron-20251003.xsd (EX-101.SCH) — 24KB
- iron-20251003_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DISC MEDICINE, INC. Date: October 6, 2025 By: /s/ John Quisel, J.D., Ph.D. John Quisel, J.D., Ph.D. Chief Executive Officer